Search Results for 'Network of Excellence for Functional Biomaterials'
6 results found.
A new world-class medical device research centre is to be established at NUI Galway as part of a €245 million national investment in science and technology announced this week. The funding will see five new Science Foundation Ireland research centres established around the country, with NUI Galway playing a key role in three of these.
Next month, the Network of Excellence for Functional Biomaterials (NFB) at NUI Galway will host a free seminar on the regulatory elements that need to be considered when developing medical devices involving a combination of advanced materials and biomolecules. The European Regulation of Medical Devices (EROMed) Seminar will take place on on October 13 in the Seminar Room of the Biosciences Building from 9.30am to 5.30pm.
The Galway Neuroscience Cluster, based within the National Centre for Biomedical Engineering Science (NCBES) at NUI Galway, last week gained the status of Centre of Excellence in Neurodegeneration (COEN) after a national and international review process. By gaining COEN status, the Galway Neuroscience Cluster joins a select group of international centres that are entitled to apply for research funding that is awarded through this international initiative.
Researchers at NUI Galway are to lead a €2.7 million European project to develop a new product for use in hernia operations.
Research and development projects in the field of medical technologies at NUI Galway are to receive an investment boost of €900,000 over the next two years from Covidien, one of the world’s leading suppliers of healthcare products.
Epidermolysis Bullosa (EB) is a genetic skin disease where blistering occurs on the skin and on internal linings such as the mouth and the intestines. It is believed to occur in an estimated one out of every 50,000 births worldwide. Those affected are often described as ‘butterfly children’ as their skin is as fragile as a butterfly’s wings.